GlassScriptPhysician profile
Amy Melvin
NPI 1326314378
$866.57
in general payments reported to CMS, 2019-2025
10 companies · $536 in 2025
The $536 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.04 · 2022: $18.99 · 2023: $144 · 2024: $126 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $273.61 | 2025 | Artix Mt, Venacore Thrombectomy Catheter, Protrieve Sheath |
| W. L. Gore & Associates, INC. | $137.31 | 2023-2025 | Gore Cardioform Septal Occluder, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Abbott Laboratories | $113.85 | 2021-2025 | Cardiomems, Amplatzer Talisman, Navitor |
| Boston Scientific Corporation | $98.74 | 2025 | Rotapro, Farapulse, General - Balloon Catheters |
| Biosense Webster, INC. | $85.27 | 2024 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $42.37 | 2023 | |
| Medtronic, INC. | $42.20 | 2021-2022 | |
| Cardiva Medical, INC. | $26.50 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Inari Medical, INC. | $26.04 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surmodics, INC. | $20.68 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Melvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.